Corrigendum to “Oxytocin Effects on Inhibition of Nf-Κb/Mir195 Pathway in Mice Breast Cancer” [Peptides 107 (2018) 54–60, (S0196978118301396), (10.1016/J.Peptides.2018.07.007)]

Corrigendum to “Oxytocin Effects on Inhibition of Nf-Κb/Mir195 Pathway in Mice Breast Cancer” [Peptides 107 (2018) 54–60, (S0196978118301396), (10.1016/J.Peptides.2018.07.007)] Publisher Pubmed

Khori V¹ ; Alizadeh AM^{2, 3} ; Khalighfard S^{2, 4} ; Heidarian Y⁵ ; Khodayari H²

Source: Peptides Published:2023

Abstract

The authors regret to inform that Figure 1D: panel Control.14 day had overlap with panel ATO.21 day at the same figure (Fig. 1D). Correction is done and we have replaced Figure 1D: panel ATO.21 day with the original figure file (attached as Fig. 1D. Panel ATO.21 day). The whole corrected Figure 1D is also attached (Edited Fig. 1D).[Formula presented][Formula presented]. The authors would like to apologise for any inconvenience caused. © 2023 Elsevier Inc.

2. Corrigendum to 'Green Porous Benzamide-Like Nanomembranes for Hazardous Cations Detection, Separation, and Concentration Adjustment’ [J. Hazard. Mater. (2022)127130] (Journal of Hazardous Materials (2022) 423(Pb), (S0304389421020987), (10.1016/J.Jhazmat.2021.127130)), Journal of Hazardous Materials (2024)

3. Retraction Note: Gamma-Radiated Immunosuppressed Tumor Xenograft Mice Can Be a New Ideal Model in Cancer Research (Scientific Reports, (2021), 11, 1, (256), 10.1038/S41598-020-80428-5), Scientific Reports (2023)

Experts (# of related papers)

Alimohammad Alizadeh (1)

Style	Citing Format
MLA	Khori V, et al.. "Corrigendum to “Oxytocin Effects on Inhibition of Nf-Κb/Mir195 Pathway in Mice Breast Cancer” [Peptides 107 (2018) 54–60, (S0196978118301396), (10.1016/J.Peptides.2018.07.007)]." Peptides, vol. 169, no. , 2023, pp. -.
APA	Khori V, Alizadeh AM, Khalighfard S, Heidarian Y, Khodayari H (2023). Corrigendum to “Oxytocin Effects on Inhibition of Nf-Κb/Mir195 Pathway in Mice Breast Cancer” [Peptides 107 (2018) 54–60, (S0196978118301396), (10.1016/J.Peptides.2018.07.007)]. Peptides, 169(), -.
Chicago	Khori V, Alizadeh AM, Khalighfard S, Heidarian Y, Khodayari H. "Corrigendum to “Oxytocin Effects on Inhibition of Nf-Κb/Mir195 Pathway in Mice Breast Cancer” [Peptides 107 (2018) 54–60, (S0196978118301396), (10.1016/J.Peptides.2018.07.007)]." Peptides 169, no. (2023): -.
Harvard	Khori V et al. (2023) 'Corrigendum to “Oxytocin Effects on Inhibition of Nf-Κb/Mir195 Pathway in Mice Breast Cancer” [Peptides 107 (2018) 54–60, (S0196978118301396), (10.1016/J.Peptides.2018.07.007)]', Peptides, 169(), pp. -.
Vancouver	Khori V, Alizadeh AM, Khalighfard S, Heidarian Y, Khodayari H. Corrigendum to “Oxytocin Effects on Inhibition of Nf-Κb/Mir195 Pathway in Mice Breast Cancer” [Peptides 107 (2018) 54–60, (S0196978118301396), (10.1016/J.Peptides.2018.07.007)]. Peptides. 2023;169():-.
BibTex	@article{ author = {Khori V and Alizadeh AM and Khalighfard S and Heidarian Y and Khodayari H}, title = {Corrigendum to “Oxytocin Effects on Inhibition of Nf-Κb/Mir195 Pathway in Mice Breast Cancer” [Peptides 107 (2018) 54–60, (S0196978118301396), (10.1016/J.Peptides.2018.07.007)]}, journal = {Peptides}, volume = {169}, number = {}, pages = {-}, year = {2023} }
RIS	TY - JOUR AU - Khori V AU - Alizadeh AM AU - Khalighfard S AU - Heidarian Y AU - Khodayari H TI - Corrigendum to “Oxytocin Effects on Inhibition of Nf-Κb/Mir195 Pathway in Mice Breast Cancer” [Peptides 107 (2018) 54–60, (S0196978118301396), (10.1016/J.Peptides.2018.07.007)] JO - Peptides VL - 169 IS - SP - EP - PY - 2023 ER -

Science Communicator Platform

Authors

Abstract